Omeros (OMER) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.40% |
| Dec 31, 2025 | -14.55% |
| Sep 30, 2025 | -25.87% |
| Jun 30, 2025 | -21.35% |
| Mar 31, 2025 | -21.50% |
| Dec 31, 2024 | -6.06% |
| Sep 30, 2024 | -5.45% |
| Jun 30, 2024 | -13.94% |
| Mar 31, 2024 | -4.66% |
| Dec 31, 2023 | -0.91% |
| Sep 30, 2023 | 2.01% |
| Jun 30, 2023 | -1.58% |
| Mar 31, 2023 | -0.09% |
| Dec 31, 2022 | 0.15% |
| Sep 30, 2022 | 4.80% |
| Jun 30, 2022 | -0.39% |
| Mar 31, 2022 | 3.51% |
| Dec 31, 2021 | 6.68% |
| Sep 30, 2021 | 17.57% |
| Jun 30, 2021 | 3.61% |
| Mar 31, 2021 | -5.85% |
| Dec 31, 2020 | 10.50% |
| Sep 30, 2020 | 9.99% |
| Jun 30, 2020 | 9.94% |
| Mar 31, 2020 | 6.67% |
| Dec 31, 2019 | -2.86% |
| Sep 30, 2019 | 15.99% |
| Jun 30, 2019 | 17.16% |
| Mar 31, 2019 | 13.54% |
| Dec 31, 2018 | 8.33% |
| Sep 30, 2018 | 5.79% |
| Jun 30, 2018 | 23.13% |
| Mar 31, 2018 | 22.10% |
| Dec 31, 2017 | 10.07% |
| Sep 30, 2017 | 39.48% |
| Jun 30, 2017 | 40.65% |
| Mar 31, 2017 | 23.70% |
| Dec 31, 2016 | 54.58% |
| Sep 30, 2016 | 40.26% |
| Jun 30, 2016 | 36.69% |
| Mar 31, 2016 | 57.38% |
| Dec 31, 2015 | 30.75% |
| Sep 30, 2015 | 32.86% |